Can Menopause Cause Incontinence? Causes & Fixes

Yes, menopause can cause incontinence. About 31% of menopausal women experience urinary leakage, and the connection comes down to one key factor: the sharp drop in estrogen that occurs during the menopausal transition. Estrogen plays a direct role in keeping your bladder and urethra functioning properly, and when levels decline, the tissues that control urine flow weaken.

Why Estrogen Loss Affects Your Bladder

Your bladder, urethra, and the surrounding pelvic tissues all contain estrogen receptors. When estrogen is circulating normally, it maintains blood flow to the urethral lining, keeps the bladder wall flexible, and supports the muscles that hold urine in. As estrogen drops during menopause, several things happen at once: the urethra can physically shorten (sometimes to just 1 to 2 centimeters), the muscles responsible for closing the urethral sphincter weaken, and the bladder becomes less compliant, meaning it can’t stretch and hold urine as well as it used to.

This collection of changes falls under what clinicians now call genitourinary syndrome of menopause, or GSM. The 2025 guidelines from the American Urological Association define GSM as the spectrum of symptoms and physical changes that result from declining estrogen and androgen levels in the genitourinary tract. Urinary symptoms of GSM include urgency, increased frequency (especially at night), burning during urination, stress or urge incontinence, and recurrent urinary tract infections. There’s no strict checklist for diagnosis. The key requirement is that the symptoms bother you and can’t be explained by something else.

Types of Incontinence Linked to Menopause

Among menopausal women who experience leakage, stress urinary incontinence is by far the most common type, accounting for nearly 60% of cases. Stress incontinence means urine leaks when physical pressure is placed on the bladder: coughing, sneezing, laughing, lifting something heavy, or exercising. The weakened urethral sphincter and thinned pelvic tissues simply can’t hold back the force.

Urge incontinence is the other main type. This is the sudden, intense need to urinate followed by involuntary leakage before you can reach a bathroom. It’s tied to changes in the bladder wall itself. Without adequate estrogen, the bladder loses capacity and becomes more prone to involuntary contractions. Some women experience both types simultaneously, which is called mixed incontinence.

When Symptoms Typically Start

The timing may surprise you. Research tracking women across the full menopausal transition found that incontinence risk actually peaks during perimenopause, not after menopause is complete. Compared to premenopausal women, those in early perimenopause were 34% more likely to develop monthly or more frequent leakage. By late perimenopause, that risk climbed to 52% higher. Postmenopausal women, on the other hand, were roughly half as likely to develop new incontinence as women still going through the transition.

This pattern held for both stress and urge incontinence. However, the menopausal transition was only linked to relatively infrequent leakage (monthly episodes). It was not associated with developing more severe, weekly incontinence. That suggests the hormonal shifts of perimenopause trigger initial symptoms, but more frequent leakage likely involves additional factors like pelvic floor damage, aging, or other health conditions.

Other Factors That Make It Worse

Menopause doesn’t operate in isolation. Several factors compound the hormonal effect and can push mild symptoms into more disruptive territory.

  • Obesity increases pressure on the pelvic floor and is consistently linked to worse incontinence outcomes, including higher rates of needing surgical intervention.
  • Childbirth history matters. Women who have had multiple vaginal deliveries enter menopause with pelvic floor muscles that may already be stretched or weakened.
  • Chronic coughing conditions like COPD create repeated strain on the pelvic floor and are specifically linked to stress and mixed incontinence in older women.
  • Cardiovascular conditions and prediabetes are associated with urge and mixed incontinence in postmenopausal women.
  • Depression has a notable link to urge incontinence across all age groups, likely through shared neurological pathways affecting bladder signaling.

Broader population data paints a striking picture: the age-adjusted prevalence of urinary incontinence among all U.S. women is 47.6%, and over 40% of those women describe their symptoms as moderate to very severe. While not all of that is menopause-related, it underscores how common the problem is and how many women are dealing with significant symptoms.

Vaginal Estrogen vs. Oral Hormone Therapy

Here’s a critical distinction that many women and even some providers get wrong: vaginal (local) estrogen helps incontinence, but oral (systemic) estrogen makes it worse.

A Cochrane review of the evidence found that women using vaginal estrogen creams or pessaries were significantly more likely to see improvement in their incontinence compared to placebo. On average, women using local estrogen had one to two fewer bathroom trips per day, along with less urgency. Side effects were minor: occasional vaginal spotting, breast tenderness, or nausea. No serious adverse events were reported.

Oral systemic estrogen told the opposite story. Across six trials, women taking oral estrogen had 32% worse incontinence than those on placebo. Even combined estrogen-progestogen therapy worsened leakage by 11%. One large study found that women who were fully continent before starting oral hormone therapy were more likely to develop new incontinence while taking it. The long-term cancer risks of systemic estrogen add another reason to avoid this route for bladder symptoms specifically.

The takeaway is straightforward: if you’re considering estrogen for urinary symptoms, vaginal application is the evidence-supported option. It delivers estrogen directly to the tissues that need it without the systemic effects that paradoxically worsen leakage.

Foods and Drinks That Irritate the Bladder

Certain foods and beverages act as bladder irritants, and cutting them out can noticeably reduce urgency and frequency. The biggest culprits are caffeine (in all forms, including chocolate and supplements), alcohol, and carbonated drinks. Citrus fruits and juices, tomatoes and tomato-based products like salsa, spicy foods, pickled foods, and onions can also amplify overactive bladder symptoms. Even high water-content foods like watermelon, cucumbers, and strawberries may contribute if your bladder is already sensitive.

Eliminating these entirely for a few weeks, then reintroducing them one at a time, is the most practical way to identify your personal triggers.

Pelvic Floor Training and Behavioral Approaches

Pelvic floor muscle exercises remain one of the most effective first-line approaches for stress incontinence. The muscles that support your bladder and urethra respond to targeted strengthening just like any other muscle group. Consistency matters more than intensity: daily practice over several months typically produces the most meaningful improvement. Working with a pelvic floor physical therapist can help you confirm you’re engaging the right muscles, since many women inadvertently use their abdominal or gluteal muscles instead.

Bladder training is particularly useful for urge incontinence. The goal is to gradually increase the intervals between bathroom visits, retraining the bladder to hold more urine. Timed voiding, where you urinate on a set schedule rather than waiting for the urge, can also help you regain a sense of control.

When Surgery Becomes an Option

For stress incontinence that doesn’t respond to conservative measures, midurethral sling procedures have strong long-term data. These involve placing a small mesh support under the urethra to prevent leakage during physical activity. At 10 years after the procedure, only 2.7% of women had their sling removed, and only about 4.5% needed a new one placed. Women in their 50s, 60s, and 70s all had similarly low removal rates (2.4% to 2.8%), suggesting the procedure holds up well regardless of age at the time of surgery.

Potential complications include chronic pain, mesh exposure in the vaginal wall, bladder perforation during the procedure, and temporary difficulty urinating afterward. Obesity and smoking or alcohol use were the strongest predictors of needing reoperation, making weight management and smoking cessation important for surgical success.